Kairos Pharma, Ltd.
KAPA
$0.96
$0.05265.80%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.22M | 21.00K | 40.00K | 93.00K | 99.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.00K | 17.00K | 19.00K | 8.00K | 17.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.52M | -- | -- | -- | -- |
| Total Current Assets | 4.74M | 38.00K | 59.00K | 101.00K | 116.00K |
|
|
|||||
| Total Current Assets | 4.74M | 38.00K | 59.00K | 101.00K | 116.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 262.00K | 302.00K | 342.00K | 382.00K | 422.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 690.00K | 571.00K | 482.00K | 410.00K |
| Total Assets | 5.00M | 1.03M | 972.00K | 965.00K | 948.00K |
|
|
|||||
| Total Accounts Payable | 1.53M | 2.90M | 2.71M | 2.40M | 2.21M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 142.00K | 106.00K | 4.00K | 4.00K | 4.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.67M | 3.01M | 2.72M | 2.41M | 2.21M |
|
|
|||||
| Total Current Liabilities | 1.67M | 3.01M | 2.72M | 2.41M | 2.21M |
| Long-Term Debt | -- | 677.00K | 657.00K | 638.00K | 612.00K |
| Short-term Debt | 142.00K | 106.00K | 4.00K | 4.00K | 4.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.67M | 3.68M | 3.37M | 3.04M | 2.82M |
|
|
|||||
| Common Stock & APIC | 11.17M | 4.13M | 4.13M | 4.13M | 3.22M |
| Retained Earnings | -7.84M | -6.79M | -6.54M | -6.21M | -5.09M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.33M | -2.65M | -2.40M | -2.08M | -1.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.33M | -2.65M | -2.40M | -2.08M | -1.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.33M | -2.65M | -2.40M | -2.08M | -1.87M |
|
|
|||||